Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Larisa V. Gubareva"'
Autor:
Margaret, Okomo-Adhiambo, Alicia M, Fry, Su, Su, Ha T, Nguyen, Anwar Abd, Elal, Elizabeth, Negron, Julie, Hand, Rebecca J, Garten, John, Barnes, Xu, Xiyan, Julie M, Villanueva, Larisa V, Gubareva, Reginald, McClinton
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 1, Pp 136-141 (2015)
Emerging Infectious Diseases
Emerging Infectious Diseases
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. During 2013–14, fifty-nine (1.2%) of 4,968 analyzed US influenza A(H1N1)pdm09 viruses had the H275Y ose
Autor:
Aaron D, Storms, Larisa V, Gubareva, Su, Su, John T, Wheeling, Margaret, Okomo-Adhiambo, Chao-Yang, Pan, Erik, Reisdorf, Kirsten, St George, Robert, Myers, Jason T, Wotton, Sara, Robinson, Brandon, Leader, Martha, Thompson, Marjorie, Shannon, Alexander, Klimov, Alicia M, Fry, Ha, Nguyen
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 2, Pp 308-311 (2012)
Emerging Infectious Diseases
Emerging Infectious Diseases
During October 2010–July 2011, 1.0% of pandemic (H1N1) 2009 viruses in the United States were oseltamivir resistant, compared with 0.5% during the 2009–10 influenza season. Of resistant viruses from 2010–11 and 2009–10, 26% and 89%, respectiv
Autor:
Larisa V. Gubareva, Katrina Sleeman, Zack Moore, Alicia M. Fry, Susan Kilpatrick, Shikha Garg, Tiffany G. Sheu
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 11, Pp 2043-2046 (2011)
Emerging Infectious Diseases
Emerging Infectious Diseases
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that
Autor:
Chao Yang Pan, Saumil Doshi, Laurie Kamimoto, Christine L. Waters, Larisa V. Gubareva, Margaret Okomo-Adhiambo, Kirsten St. George, Samuel B. Graitcer, Alexander Klimov, Zack Moore, Alicia M. Fry, Steven A. Marshall, Meredith Vandermeer, Jennifer Laplante, Janice K. Louie, Katrina Sleeman
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 17, Iss 2, Pp 255-257 (2011)
Emerging Infectious Diseases, Vol 17, Iss 2, Pp 255-257 (2011)
During April 2009–June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and h